chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Oedema peripheral
Clinical narrative: after the 2nd dose she started to have issues with her left foot/serious problems with her feet and legs ever since; both of her feet and legs swelled up, they are puffy at touch; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (after the 2nd dose she started to have issues with her left foot/serious problems with her feet and legs ever since) and EDEMA PERIPHERAL (both of her feet and legs swelled up, they are puffy at touch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced LIMB DISCOMFORT (after the 2nd dose she started to have issues with her left foot/serious problems with her feet and legs ever since) and EDEMA PERIPHERAL (both of her feet and legs swelled up, they are puffy at touch). At the time of the report, LIMB DISCOMFORT (after the 2nd dose she started to have issues with her left foot/serious problems with her feet and legs ever since) had not resolved and EDEMA PERIPHERAL (both of her feet and legs swelled up, they are puffy at touch) outcome was unknown.            No relevant concomitant medications were reported.  Treatment products included diphenhydramine (Benadryl) and 2 different antibiotics.   This case was linked to MOD-2021-218749 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: TCR Follow up received on 02-JUL-2021 contains Non-Significant information, Mailing address updated.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). On 18-May-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Pharmacy Technician found a box of Moderna Covid-19 vaccine that had a letter with the vaccine dated 16MAR2021 which stated that these batches of vaccine expired on 28 Apr 2021. The pharmacist reported that the patients received expired Moderna Covid-19 vaccine since 28 Apr 2021.  No relevant concomitant medications were reported. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Induration, Pyrexia, Rash macular
Clinical narrative: huge red spot with a knot in it and it's hard; huge red spot with a knot in it and it's hard; huge red spot with a knot in it and it's hard; chills; horrible headache; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Jun-2021 and was forwarded to Moderna on 14-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (huge red spot with a knot in it and it's hard), INDURATION (huge red spot with a knot in it and it's hard), SWELLING (huge red spot with a knot in it and it's hard), CHILLS (chills) and HEADACHE (horrible headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced RASH MACULAR (huge red spot with a knot in it and it's hard), INDURATION (huge red spot with a knot in it and it's hard), SWELLING (huge red spot with a knot in it and it's hard), CHILLS (chills), HEADACHE (horrible headache) and PYREXIA (fever). At the time of the report, RASH MACULAR (huge red spot with a knot in it and it's hard), INDURATION (huge red spot with a knot in it and it's hard), SWELLING (huge red spot with a knot in it and it's hard), CHILLS (chills), HEADACHE (horrible headache) and PYREXIA (fever) outcome was unknown.            Treatment information was not provided.  No concomitant medications were reported.  On 11 Jun 2021, The patient reported after they got their  second vaccine yesterday that they have a huge red spot with a knot in it and it's hard. The patient is also  experiencing chills, possibly a fever and a horrible headache.
Sex: U
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: huge red spot with a knot in it and it's hard; huge red spot with a knot in it and it's hard; huge red spot with a knot in it and it's hard; chills; horrible headache; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Jun-2021 and was forwarded to Moderna on 14-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (huge red spot with a knot in it and it's hard), INDURATION (huge red spot with a knot in it and it's hard), SWELLING (huge red spot with a knot in it and it's hard), CHILLS (chills) and HEADACHE (horrible headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced RASH MACULAR (huge red spot with a knot in it and it's hard), INDURATION (huge red spot with a knot in it and it's hard), SWELLING (huge red spot with a knot in it and it's hard), CHILLS (chills), HEADACHE (horrible headache) and PYREXIA (fever). At the time of the report, RASH MACULAR (huge red spot with a knot in it and it's hard), INDURATION (huge red spot with a knot in it and it's hard), SWELLING (huge red spot with a knot in it and it's hard), CHILLS (chills), HEADACHE (horrible headache) and PYREXIA (fever) outcome was unknown.            Treatment information was not provided.  No concomitant medications were reported.  On 11 Jun 2021, The patient reported after they got their  second vaccine yesterday that they have a huge red spot with a knot in it and it's hard. The patient is also  experiencing chills, possibly a fever and a horrible headache.
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Vaginal bleeding after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Vaginal bleeding after vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VAGINAL HAEMORRHAGE (Vaginal bleeding after vaccination). At the time of the report, VAGINAL HAEMORRHAGE (Vaginal bleeding after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment details not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Mass, Urticaria
Clinical narrative: Lumps on her forehead; first dose on 06 may 2021 and second dose on 26 May 2021; welts on my forehead; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Lumps on her forehead), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 06 may 2021 and second dose on 26 May 2021) and URTICARIA (welts on my forehead) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MASS (Lumps on her forehead), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 06 may 2021 and second dose on 26 May 2021) and URTICARIA (welts on my forehead). At the time of the report, MASS (Lumps on her forehead), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 06 may 2021 and second dose on 26 May 2021) and URTICARIA (welts on my forehead) outcome was unknown.            No relevant concomitant medication was reported.  Treatment information was not provided.  Patient receive the second dose of vaccine on 26 May 2021 and had Botox injection 2 weeks after that .She had lumps on her forehead.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: New event added, welts on my forehead
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Knot to left upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Knot to left upper arm) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced VACCINATION SITE SWELLING (Knot to left upper arm). At the time of the report, VACCINATION SITE SWELLING (Knot to left upper arm) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 25-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications are reported. No treatment medication details was reported.   This case was linked to MOD-2021-218790 (Patient Link).
Age: 18.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). On 10-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported. No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Feeling hot, Incorrect route of product administration, Pain in extremity, Peripheral swelling
Clinical narrative: resembled cellulitis; arm drained a little bit at the injection site; Some bruising; hot to touch; arm soreness/Arm sore later in the day; arm swollen; they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (resembled cellulitis), PAIN IN EXTREMITY (arm soreness/Arm sore later in the day), PERIPHERAL SWELLING (arm swollen), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous) and FEELING HOT (hot to touch) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. WM6628 and WM6638) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 10-Jun-2021, the patient experienced PAIN IN EXTREMITY (arm soreness/Arm sore later in the day), PERIPHERAL SWELLING (arm swollen) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous). On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (resembled cellulitis), FEELING HOT (hot to touch), VACCINATION SITE DISCHARGE (arm drained a little bit at the injection site) and CONTUSION (Some bruising). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swollen arm, at a dose of 1 UNK and PARACETAMOL (TYLENOL) for Swollen arm, at a dose of 1 UNK. On 12-Jun-2021, PAIN IN EXTREMITY (arm soreness/Arm sore later in the day) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (resembled cellulitis), PERIPHERAL SWELLING (arm swollen), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous), FEELING HOT (hot to touch), VACCINATION SITE DISCHARGE (arm drained a little bit at the injection site) and CONTUSION (Some bruising) outcome was unknown.            Concomitant product use was not provided by the reporter.  Patient also took baking soda + water paste to their arm to alleviate the symptoms.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up information received on 14-JUN-2021 contains no new information On 04-Aug-2021: Fallow up received and reporter address were added.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site cellulitis, Vaccination site discharge
Clinical narrative: resembled cellulitis; arm drained a little bit at the injection site; Some bruising; hot to touch; arm soreness/Arm sore later in the day; arm swollen; they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (resembled cellulitis), PAIN IN EXTREMITY (arm soreness/Arm sore later in the day), PERIPHERAL SWELLING (arm swollen), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous) and FEELING HOT (hot to touch) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. WM6628 and WM6638) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 10-Jun-2021, the patient experienced PAIN IN EXTREMITY (arm soreness/Arm sore later in the day), PERIPHERAL SWELLING (arm swollen) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous). On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (resembled cellulitis), FEELING HOT (hot to touch), VACCINATION SITE DISCHARGE (arm drained a little bit at the injection site) and CONTUSION (Some bruising). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swollen arm, at a dose of 1 UNK and PARACETAMOL (TYLENOL) for Swollen arm, at a dose of 1 UNK. On 12-Jun-2021, PAIN IN EXTREMITY (arm soreness/Arm sore later in the day) had resolved. At the time of the report, VACCINATION SITE CELLULITIS (resembled cellulitis), PERIPHERAL SWELLING (arm swollen), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (they believed subq injection instead of muscle/Dose was not in the muscle, more like subcutaneous), FEELING HOT (hot to touch), VACCINATION SITE DISCHARGE (arm drained a little bit at the injection site) and CONTUSION (Some bruising) outcome was unknown.            Concomitant product use was not provided by the reporter.  Patient also took baking soda + water paste to their arm to alleviate the symptoms.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up information received on 14-JUN-2021 contains no new information On 04-Aug-2021: Fallow up received and reporter address were added.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Food craving, Muscle spasms, Uterine contractions abnormal, Vaginal haemorrhage
Clinical narrative: Vaginal bleeding /  bleeding felt like menstrual period; Cramping; Cravings; Womb hurting like contractions; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Vaginal bleeding /  bleeding felt like menstrual period), MUSCLE SPASMS (Cramping), FOOD CRAVING (Cravings) and UTERINE CONTRACTIONS ABNORMAL (Womb hurting like contractions) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HCTZ) for Blood pressure, ATORVASTATIN for Cholesterol, METFORMIN, Glipezide and SITAGLIPTIN PHOSPHATE (JANUVIA) for Diabetes mellitus.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced VAGINAL HAEMORRHAGE (Vaginal bleeding /  bleeding felt like menstrual period), MUSCLE SPASMS (Cramping), FOOD CRAVING (Cravings) and UTERINE CONTRACTIONS ABNORMAL (Womb hurting like contractions). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) at an unspecified dose and frequency. On 09-Jun-2021, VAGINAL HAEMORRHAGE (Vaginal bleeding /  bleeding felt like menstrual period), MUSCLE SPASMS (Cramping), FOOD CRAVING (Cravings) and UTERINE CONTRACTIONS ABNORMAL (Womb hurting like contractions) had resolved.
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Weight loss/ lost 6lb in two days after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (Weight loss/ lost 6lb in two days after the second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WEIGHT DECREASED (Weight loss/ lost 6lb in two days after the second dose). At the time of the report, WEIGHT DECREASED (Weight loss/ lost 6lb in two days after the second dose) outcome was unknown.            No concomitant medications were reported by the reporter.  Treatment medication was not provided by the reporter.   Reporter did not allow further contact
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Chills, Headache, Lymphadenopathy, Nausea
Clinical narrative: rapid heartbeat once a while and it has happened four times; Feverish; Headache; Chills; nausea; Taste buds were off; Enlarged lymph node below the chin; Sleeps a lot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Jun-2021 and was forwarded to Moderna on 11-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of AGEUSIA (Taste buds were off), LYMPHADENOPATHY (Enlarged lymph node below the chin), SOMNOLENCE (Sleeps a lot), TACHYCARDIA (rapid heartbeat once a while and it has happened four times) and PYREXIA (Feverish) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced AGEUSIA (Taste buds were off), LYMPHADENOPATHY (Enlarged lymph node below the chin), SOMNOLENCE (Sleeps a lot), PYREXIA (Feverish), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (nausea). On an unknown date, the patient experienced TACHYCARDIA (rapid heartbeat once a while and it has happened four times). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form and ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, AGEUSIA (Taste buds were off), LYMPHADENOPATHY (Enlarged lymph node below the chin), SOMNOLENCE (Sleeps a lot), PYREXIA (Feverish), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (nausea) had not resolved and TACHYCARDIA (rapid heartbeat once a while and it has happened four times) outcome was unknown.            No relevant concomitant medications were reported.  Additional treatment medication included pain reliever.   This case was linked to MOD-2021-218773 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence, Tachycardia
Clinical narrative: rapid heartbeat once a while and it has happened four times; Feverish; Headache; Chills; nausea; Taste buds were off; Enlarged lymph node below the chin; Sleeps a lot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Jun-2021 and was forwarded to Moderna on 11-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of AGEUSIA (Taste buds were off), LYMPHADENOPATHY (Enlarged lymph node below the chin), SOMNOLENCE (Sleeps a lot), TACHYCARDIA (rapid heartbeat once a while and it has happened four times) and PYREXIA (Feverish) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced AGEUSIA (Taste buds were off), LYMPHADENOPATHY (Enlarged lymph node below the chin), SOMNOLENCE (Sleeps a lot), PYREXIA (Feverish), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (nausea). On an unknown date, the patient experienced TACHYCARDIA (rapid heartbeat once a while and it has happened four times). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form and ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, AGEUSIA (Taste buds were off), LYMPHADENOPATHY (Enlarged lymph node below the chin), SOMNOLENCE (Sleeps a lot), PYREXIA (Feverish), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (nausea) had not resolved and TACHYCARDIA (rapid heartbeat once a while and it has happened four times) outcome was unknown.            No relevant concomitant medications were reported.  Additional treatment medication included pain reliever.   This case was linked to MOD-2021-218773 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Spinal pain
Clinical narrative: missed her second shot; real bad spinal cord pain for 2 days/back was hurting; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (real bad spinal cord pain for 2 days/back was hurting) and PRODUCT DOSE OMISSION ISSUE (missed her second shot) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07B21A) for COVID-19 vaccination.     The Medical History was not provided by the reporter.     On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced SPINAL PAIN (real bad spinal cord pain for 2 days/back was hurting). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her second shot). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 10-Apr-2021, SPINAL PAIN (real bad spinal cord pain for 2 days/back was hurting) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed her second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). On 18-May-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: follow up received-no new information found
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Syringe malfunction while administering the second dose; A large quantity of the vaccine came out of the syringe; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (Syringe malfunction while administering the second dose) and UNDERDOSE (A large quantity of the vaccine came out of the syringe) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 12-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 12-Jun-2021, the patient experienced DEVICE CONNECTION ISSUE (Syringe malfunction while administering the second dose) and UNDERDOSE (A large quantity of the vaccine came out of the syringe). At the time of the report, DEVICE CONNECTION ISSUE (Syringe malfunction while administering the second dose) and UNDERDOSE (A large quantity of the vaccine came out of the syringe) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expire Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expire Moderna Covid-19 vaccine) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expire Moderna Covid-19 vaccine). On 18-May-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expire Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: administering second dose who is 5 days early at day 21; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administering second dose who is 5 days early at day 21) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administering second dose who is 5 days early at day 21). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administering second dose who is 5 days early at day 21) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Getting 2nd shot at day 49 after the 1st shot; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Getting 2nd shot at day 49 after the 1st shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Gallbladder operation NOS (1 week after the 1st vaccine dose was administered).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Getting 2nd shot at day 49 after the 1st shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Getting 2nd shot at day 49 after the 1st shot) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Pyrexia, Vaccination site pain
Clinical narrative: Dry and chapped lips; First injection stung a bit; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of CHAPPED LIPS (Dry and chapped lips), VACCINATION SITE PAIN (First injection stung a bit) and PYREXIA (Low grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21a) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and OXYCODONE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHAPPED LIPS (Dry and chapped lips), VACCINATION SITE PAIN (First injection stung a bit) and PYREXIA (Low grade fever). At the time of the report, CHAPPED LIPS (Dry and chapped lips) and VACCINATION SITE PAIN (First injection stung a bit) outcome was unknown and PYREXIA (Low grade fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications also included unspecified thyroid medication. No treatment information was provided.   This case was linked to MOD-2021-218718 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: r arm is in pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (r arm is in pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (r arm is in pain). At the time of the report, PAIN IN EXTREMITY (r arm is in pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant and Treatment information were reported.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Administered vaccine 7 days early; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Administered vaccine 7 days early) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Administered vaccine 7 days early). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Administered vaccine 7 days early) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: heat coming off of the area the vaccine was administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (heat coming off of the area the vaccine was administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (heat coming off of the area the vaccine was administered). At the time of the report, VACCINATION SITE WARMTH (heat coming off of the area the vaccine was administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant was provided no treatment drug was provided
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Headache
Clinical narrative: Headache; Arm was red; Arm was hot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and HEADACHE (Headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011D21A and 027C21A) for COVID-19 vaccination.     Concomitant products included COLECALCIFEROL (VITAMIN D3), INSULIN HUMAN, MULTIVITAMIN [VITAMINS NOS], DESLORATADINE and AZELASTINE for an unknown indication.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jun-2021, the patient experienced ERYTHEMA (Arm was red) and FEELING HOT (Arm was hot). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, ERYTHEMA (Arm was red) and FEELING HOT (Arm was hot) had not resolved and HEADACHE (Headache) outcome was unknown.            concomitant medication include Diabetes medicine. no treatment medication was given
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of underdose (liquid splashed out when she depressed the plunger) and device connection issue (liquid splashed out when she depressed the plunger) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 016C21A and 050C21A) for COVID-19 immunization. No medical history reported. On May 14, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jun 11, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Jun 11, 2021, patient experienced underdose (liquid splashed out when she depressed the plunger) and device connection issue (liquid splashed out when she depressed the plunger). On Jun 11, 2021, underdose (liquid splashed out when she depressed the plunger) and device connection issue (liquid splashed out when she depressed the plunger) resolved. The reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the events: not applicable. Concomitant product use and treatment information not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: really sore arm; arm was not as sore; muscle ache; Joint pain; Headaches; Fatigue, stayed in bed; fever of 101.3 °F; like a light case of the flue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (like a light case of the flue), PAIN IN EXTREMITY (really sore arm), PAIN IN EXTREMITY (arm was not as sore), MYALGIA (muscle ache) and ARTHRALGIA (Joint pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RIVAROXABAN (XARELTO), GABAPENTIN, ATENOLOL, TRAMADOL and LINACLOTIDE (LINZESS) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (like a light case of the flue), PAIN IN EXTREMITY (arm was not as sore), MYALGIA (muscle ache), ARTHRALGIA (Joint pain), HEADACHE (Headaches), FATIGUE (Fatigue, stayed in bed) and PYREXIA (fever of 101.3 °F). On an unknown date, the patient experienced PAIN IN EXTREMITY (really sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 06-Mar-2021, INFLUENZA LIKE ILLNESS (like a light case of the flue), PAIN IN EXTREMITY (arm was not as sore), MYALGIA (muscle ache), ARTHRALGIA (Joint pain), HEADACHE (Headaches), FATIGUE (Fatigue, stayed in bed) and PYREXIA (fever of 101.3 °F) had resolved. At the time of the report, PAIN IN EXTREMITY (really sore arm) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: really sore arm; arm was not as sore; muscle ache; Joint pain; Headaches; Fatigue, stayed in bed; fever of 101.3 °F; like a light case of the flue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (like a light case of the flue), PAIN IN EXTREMITY (really sore arm), PAIN IN EXTREMITY (arm was not as sore), MYALGIA (muscle ache) and ARTHRALGIA (Joint pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RIVAROXABAN (XARELTO), GABAPENTIN, ATENOLOL, TRAMADOL and LINACLOTIDE (LINZESS) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (like a light case of the flue), PAIN IN EXTREMITY (arm was not as sore), MYALGIA (muscle ache), ARTHRALGIA (Joint pain), HEADACHE (Headaches), FATIGUE (Fatigue, stayed in bed) and PYREXIA (fever of 101.3 °F). On an unknown date, the patient experienced PAIN IN EXTREMITY (really sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 06-Mar-2021, INFLUENZA LIKE ILLNESS (like a light case of the flue), PAIN IN EXTREMITY (arm was not as sore), MYALGIA (muscle ache), ARTHRALGIA (Joint pain), HEADACHE (Headaches), FATIGUE (Fatigue, stayed in bed) and PYREXIA (fever of 101.3 °F) had resolved. At the time of the report, PAIN IN EXTREMITY (really sore arm) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Hypertension, Hypoaesthesia, Vomiting
Clinical narrative: blood pressure continues to rise; numbness; feels the need to vomit; This spontaneous case was reported by a patient and describes the occurrence of HYPERTENSION (blood pressure continues to rise), HYPOAESTHESIA (numbness) and VOMITING (feels the need to vomit) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknonw) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (blood pressure continues to rise), HYPOAESTHESIA (numbness) and VOMITING (feels the need to vomit). At the time of the report, HYPERTENSION (blood pressure continues to rise), HYPOAESTHESIA (numbness) and VOMITING (feels the need to vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that his blood pressure was continuing to rise all day, numbness, and felt like vomiting. No concomitant medications were reported.  No treatment information was reported.